Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 17Unknown 8Recruiting 8Active not recruiting 6Terminated 3Withdrawn 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 8

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 8

Conditions

Breast Neoplasms 1872Neoplasms 1257Colorectal Neoplasms 1059Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 803Carcinoma, Hepatocellular 785Lung Neoplasms 769Prostatic Neoplasms 697Pancreatic Neoplasms 577Rectal Neoplasms 450Ovarian Neoplasms 406Neoplasm Metastasis 405Colonic Neoplasms 405Uterine Cervical Neoplasms 400Recurrence 383Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 340Lymphoma 335Head and Neck Neoplasms 330Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 264Urinary Bladder Neoplasms 256Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 216Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 205

Interventions

irinotecan sucrosofate 1folfirinox 1Taxes 1Surgical Procedures, Operative 1Radiotherapy 1Radiosurgery 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Unknown × Pancreatic Adenocarcinoma × Clear all
NCT04143152 2024-04-23

Pancreatic Cancer Biomarker Study

Van Andel Research Institute

Unknown
300 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT05181605 2022-08-09

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Instituto de investigación e innovación biomédica de Cádiz

Phase 2/3 Unknown
116 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02839343 2022-05-24

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Unknown
126 enrolled 12 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown
67 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT04835064 2021-04-08

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

Fudan University

Phase 3 Unknown
600 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT04814251 2021-03-24

THROMPAN

Poitiers University Hospital

Unknown
200 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03840460 2020-02-20

PaC-MAn

Royal Marsden NHS Foundation Trust

Unknown
200 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03673423 2018-12-13

OBTCPAN

Ospedale San Raffaele

Unknown
138 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡